Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can your phone hear your baby kick? new app aims to monitor fetal movements

NCT ID NCT07626112

Knowledge-focused Sponsor: Kenneth Moise MD Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 15, 2026 · Updated 5 times

Summary

This pilot study will test a smartphone app called Womb Watch that uses the phone's microphone to listen for fetal movements, like kicks, breathing, and hiccups. About 60 pregnant women between 28 and 40 weeks will record audio daily for 15 minutes. The goal is to see if the app is easy to use and if artificial intelligence can accurately detect movements, which could help monitor high-risk pregnancies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Smartphone application (Womb Watch app) using the phone's microphone
What this could lead to
If successful, this could lead to a simple, at-home tool for pregnant women to monitor fetal movements, potentially reducing stillbirth risk.
What could go wrong
This is a small, early feasibility study with only 60 participants. The app may not work well across different phone models or in real-world conditions, and it is not yet proven to prevent complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pregnant women between 28 - 40 weeks of gestation with a singleton pregnancy.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Ability to understand and voluntarily provide written signed informed consent to participate in the study. * English speaking (the alpha version of the Womb Watch app is only available in English) * Singleton intrauterine pregnancy * Estimated gestational age at enrollment 28 weeks to 32 weeks * Low-risk pregnancy with normal fetal growth and anatomy and no maternal co-morbidities of note. * High-risk pregnancy including fetal anomalies and maternal co-morbidities including but not limited to cardiovascular, pulmonary, hepatic, renal, hematologic, gastrointestinal, endocrine/metabolic, immunologic, dermatologic, neurologic, or oncologic. * No prior diagnosis of an anxiety mood disorder or a psychiatric illness * Access to internet * A functioning email address * Owns personal smartphone; iPhone or Android of any generation Exclusion Criteria: * Currently pregnant with multiples (twins or more) * Baseline GAD-7 score of 10 or more

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Assessment of fetal movement are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

disease Fetal Death pregnancy disorder pregnancy disorder with abortive outcome Stillbirth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Assessment of fetal movement Fetal movement Pregnancy Pregnancy complications Pregnancy complications affecting fetus (diagnosis) Stillbirth Stillbirth and neonatal mortality

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    3 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Dell Medical School- University of Texas at Austin

    RECRUITING

    Austin, Texas, 78723, United States

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

  • McGovern Medical School - UTHealth Houston

    RECRUITING

    Houston, Texas, 77030, United States

  • University of Texas Medical Branch at Galveston - UTMB Health

    RECRUITING

    Galveston, Texas, 77555, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.